Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Acute Promyelocytic Leukemia (APL)”

165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 165 results

Testing effectiveness (Phase 2)Study completedNCT00551460
What this trial is testing

S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 78
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT00077558
What this trial is testing

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Enrolling By InvitationNCT06544109
What this trial is testing

Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Who this might be right for
Acute Promyelocytic Leukemia
The First Affiliated Hospital of Soochow University 98
Early research (Phase 1)Study completedNCT00004009
What this trial is testing

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore
Early research (Phase 1)Study completedNCT01139970
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+13 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)WithdrawnNCT00670150
What this trial is testing

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
University of Southern California
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Not applicableStudy completedNCT01146223
What this trial is testing

Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)+1 more
Children's Oncology Group 10
Early research (Phase 1)Study completedNCT00002588
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

Who this might be right for
Leukemia
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT01064570
What this trial is testing

AIDA 2000 Guidelines

Who this might be right for
Acute Promyelocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 600
Early research (Phase 1)Study completedNCT00015925
What this trial is testing

MS-275 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)UnknownNCT00454168
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Leukemia
The Vaccine Company 244
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Post-approval studies (Phase 4)UnknownNCT04446806
What this trial is testing

Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia

Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 100
Post-approval studies (Phase 4)Study completedNCT00465933
What this trial is testing

Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)

Who this might be right for
Acute Promyelocytic Leukemia
PETHEMA Foundation
Large-scale testing (Phase 3)UnknownNCT00002658
What this trial is testing

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaNeutropenia
Medical Research Council 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT04687176
What this trial is testing

Frontline Oral Arsenic Trioxide for APL

Who this might be right for
Acute Promyelocytic Leukemia
The University of Hong Kong 100
Not applicableActive Not RecruitingNCT03253848
What this trial is testing

Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia With PML-RARAt(15;17)
ECOG-ACRIN Cancer Research Group 202
Load More Results